Modulus Therapeutics

Developer of immune cell therapies for the treatment of solid tumors

placeSeattle, Washington, United States calendar_todayFounded 2020 groups10 employees language modulustherapeutics.com

Registered entities

Investor mix

4 investors on record; lead investors include Madrona.

Investor typeCountShare
Venture capital250%
Accelerator & incubator125%
Other / undisclosed125%
Coming soon